Jump Financial, LLC Castle Biosciences Inc Transaction History

Jump Financial, LLC

  • $4.3 Billion
  • Q4 2024

A detailed history of Jump Financial, LLC transactions in Castle Biosciences Inc stock. As of the latest transaction made, Jump Financial, LLC holds 11,400 shares of CSTL stock, worth $230,394. This represents 0.01% of its overall portfolio holdings.

Number of Shares
11,400
Previous 36,136 68.45%
Holding current value
$230,394
Previous $1.03 Million 70.58%
% of portfolio
0.01%
Previous 0.02%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
SELL
$26.52 - $34.67 $655,998 - $857,597
-24,736 Reduced 68.45%
11,400 $303,000
Q3 2024

Nov 14, 2024
BUY
$17.4 - $31.47 $628,766 - $1.14 Million
36,136 New
36,136 $1.03 Million
Q4 2023

Oct 21, 2024
SELL
$12.19 - $22.43 $43,445 - $79,940
-3,564 Reduced 14.85%
20,436 $441,000
Q4 2023

Feb 07, 2024
SELL
$12.19 - $22.43 $43,445 - $79,940
-3,564 Reduced 14.85%
20,436 $441,000
Q3 2023

Oct 21, 2024
BUY
$13.28 - $20.3 $57,104 - $87,290
4,300 Added 21.83%
24,000 $405,000
Q3 2023

Nov 07, 2023
BUY
$13.28 - $20.3 $57,104 - $87,290
4,300 Added 21.83%
24,000 $405,000
Q2 2023

Oct 21, 2024
BUY
$11.66 - $26.0 $26,818 - $59,800
2,300 Added 13.22%
19,700 $270,000
Q2 2023

Aug 07, 2023
BUY
$11.66 - $26.0 $26,818 - $59,800
2,300 Added 13.22%
19,700 $270,000
Q1 2023

Oct 21, 2024
BUY
$19.47 - $28.49 $338,778 - $495,726
17,400 New
17,400 $395,000
Q1 2023

May 03, 2023
SELL
$19.47 - $28.49 $36,993 - $54,131
-1,900 Reduced 9.84%
17,400 $395,000
Q4 2022

Feb 13, 2023
SELL
$18.08 - $30.0 $18,188 - $30,180
-1,006 Reduced 4.95%
19,300 $454,000
Q3 2022

Nov 07, 2022
BUY
$22.51 - $34.32 $60,912 - $92,869
2,706 Added 15.38%
20,306 $530,000
Q2 2022

Aug 09, 2022
BUY
$16.0 - $45.99 $22,368 - $64,294
1,398 Added 8.63%
17,600 $386,000
Q1 2022

May 12, 2022
SELL
$33.17 - $46.98 $465,773 - $659,693
-14,042 Reduced 46.43%
16,202 $727,000
Q4 2021

Feb 10, 2022
BUY
$39.06 - $67.58 $958,688 - $1.66 Million
24,544 Added 430.6%
30,244 $1.3 Million
Q3 2021

Nov 12, 2021
SELL
$60.13 - $77.6 $66,143 - $85,360
-1,100 Reduced 16.18%
5,700 $379,000
Q2 2021

Aug 13, 2021
BUY
$50.07 - $76.78 $340,476 - $522,104
6,800 New
6,800 $499,000
Q4 2020

Feb 12, 2021
SELL
$43.6 - $73.05 $173,092 - $290,008
-3,970 Closed
0 $0
Q3 2020

Nov 13, 2020
BUY
$38.47 - $52.03 $152,725 - $206,559
3,970 New
3,970 $204,000

Others Institutions Holding CSTL

# of Institutions
210
Shares Held
26.6M
Call Options Held
128K
Put Options Held
35.4K
View Full List

About CASTLE BIOSCIENCES INC

CSTL Quotes by TradingView
  • Ticker CSTL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 26,297,000
  • Market Cap $531M
  • Description
  • Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...
More about CSTL
Track This Portfolio

Track Jump Financial, LLC Portfolio

Follow Jump Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jump Financial, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email